loading
Precedente Chiudi:
$2.58
Aprire:
$2.62
Volume 24 ore:
142.59K
Relative Volume:
0.96
Capitalizzazione di mercato:
$101.10M
Reddito:
$2.70M
Utile/perdita netta:
$5.53M
Rapporto P/E:
23.27
EPS:
0.11
Flusso di cassa netto:
$-10.55M
1 W Prestazione:
+9.40%
1M Prestazione:
+7.11%
6M Prestazione:
+20.75%
1 anno Prestazione:
+9.40%
Intervallo 1D:
Value
$2.52
$2.65
Intervallo di 1 settimana:
Value
$2.32
$2.65
Portata 52W:
Value
$1.82
$3.09

Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile

Name
Nome
Oramed Pharmaceuticals Inc
Name
Telefono
646-844-1164
Name
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Name
Dipendente
13
Name
Cinguettio
@OramedPharma
Name
Prossima data di guadagno
2025-08-19
Name
Ultimi documenti SEC
Name
ORMP's Discussions on Twitter

Confronta ORMP con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ORMP
Oramed Pharmaceuticals Inc
2.54 102.69M 2.70M 5.53M -10.55M 0.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
429.54 108.28B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
763.80 79.44B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
441.84 57.65B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
903.51 56.58B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
204.78 42.39B 447.02M -1.18B -906.14M -6.1812

Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-01-12 Downgrade Canaccord Genuity Buy → Hold
2022-02-18 Iniziato Cantor Fitzgerald Overweight
2021-04-20 Iniziato Canaccord Genuity Buy
2021-02-09 Iniziato National Securities Buy
2020-12-03 Iniziato Alliance Global Partners Buy
2020-03-11 Iniziato Aegis Capital Buy
2019-09-11 Iniziato Ladenburg Thalmann Buy
2017-12-11 Ripresa B. Riley FBR, Inc. Buy
2016-05-26 Reiterato FBR Capital Outperform
2015-12-01 Reiterato H.C. Wainwright Buy
2015-11-19 Iniziato FBR Capital Outperform
2015-04-13 Ripresa MLV & Co Buy
2014-01-30 Reiterato Aegis Capital Buy
2014-01-08 Reiterato Aegis Capital Buy
2014-01-08 Iniziato MLV & Co Buy
2013-12-03 Iniziato Aegis Capital Buy
Mostra tutto

Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie

pulisher
Nov 22, 2025

Oramed Pharm Repurchases Shares, Ends Joint Venture - MSN

Nov 22, 2025
pulisher
Nov 21, 2025

There Are Some Holes In Oramed Pharmaceuticals' (NASDAQ:ORMP) Solid Earnings Release - Yahoo Finance

Nov 21, 2025
pulisher
Nov 21, 2025

Oramed Pharmaceuticals' (NASDAQ:ORMP) Profits May Be Overstating Its True Earnings Potential - simplywall.st

Nov 21, 2025
pulisher
Nov 21, 2025

Why Oramed Pharmaceuticals Inc. (OJU1) stock attracts HNW investorsTrade Analysis Report & Expert Approved Momentum Ideas - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

How Oramed Pharmaceuticals Inc. (OJU1) stock correlates with oil marketsTrade Risk Report & Smart Swing Trading Techniques - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

What market sentiment indicators show for Oramed Pharmaceuticals Inc. (OJU1) stockMarket Rally & High Accuracy Trade Signal Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Oramed Pharmaceuticals Inc. stock overvalued by current metricsBull Run & Consistent Return Strategy Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Oramed Pharmaceuticals Inc. (OJU1) stock performs during market turbulence2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Oramed Pharmaceuticals Inc. (OJU1) stock vulnerable to rate hikes2025 Top Decliners & AI Driven Price Predictions - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is Oramed Pharmaceuticals Inc. (OJU1) stock a fit for income portfoliosQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Oramed Pharmaceuticals Inc. stock a top pick in earnings seasonQuarterly Market Summary & Stepwise Swing Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What recovery options are there for Oramed Pharmaceuticals Inc.Market Performance Summary & AI Powered Market Entry Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can technical indicators confirm Oramed Pharmaceuticals Inc.’s reversal2025 Short Interest & Free Growth Oriented Trading Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Tools to assess Oramed Pharmaceuticals Inc.’s risk profile2025 Historical Comparison & Accurate Intraday Trade Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Forecasting Oramed Pharmaceuticals Inc. price range with options dataCPI Data & High Return Stock Watch Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Oramed Pharmaceuticals Inc. (OJU1) stock maintain strong growth2025 Key Highlights & Weekly High Return Stock Opportunities - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What sentiment indicators say about Oramed Pharmaceuticals Inc. stock2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 00:19:35 - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Published on: 2025-11-22 06:20:56 - earlytimes.in

Nov 18, 2025
pulisher
Nov 18, 2025

Is Oramed Pharmaceuticals Inc a good long term investmentMarket Capitalization Trends & Small Investment Trading Plans - earlytimes.in

Nov 18, 2025
pulisher
Nov 18, 2025

Oramed Pharm Declares Dividend Amidst Takeover Defense - MSN

Nov 18, 2025
pulisher
Nov 17, 2025

MSN Money - MSN

Nov 17, 2025

Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$39.15
price up icon 0.53%
$30.83
price up icon 1.22%
$106.12
price up icon 3.95%
$97.48
price up icon 1.98%
biotechnology ONC
$350.25
price up icon 0.97%
$205.01
price up icon 3.13%
Capitalizzazione:     |  Volume (24 ore):